US HB2558 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on May 19 2017 - 25% progression, died in committee
Action: 2017-05-26 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 19 2017 - 25% progression, died in committee
Action: 2017-05-26 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Patient Safety and Toxicology Modernization Act of 2017 This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models.
Title
Patient Safety and Toxicology Modernization Act of 2017
Sponsors
| Rep. Chris Collins [R-NY] | Rep. Billy Long [R-MO] | Rep. Scott Peters [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-05-26 | House | Referred to the Subcommittee on Health. |
| 2017-05-19 | House | Referred to the House Committee on Energy and Commerce. |
| 2017-05-19 | House | Introduced in House |
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Medical research
Medical tests and diagnostic methods
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Medical research
Medical tests and diagnostic methods
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/2558/all-info |
| Text | https://www.congress.gov/115/bills/hr2558/BILLS-115hr2558ih.pdf |
